A novel machine learning model for autonomous analysis and diagnosis of well integrity failures in artificial-lift production systems

The integrity failure in gas lift wells had been proven to be more severe than other artificial lift wells across the industry. Accurate risk assessment is an essential requirement for predicting well integrity failures. In this study, a machine learning model was established for automated and precise prediction of integrity failures in gas lift wells. The collected data contained 9,000 data arrays with 23 features. Data arrays were structured and fed into 11 different machine learning algorithms to build an automated systematic tool for calculating the imposed risk of any well. The study models included both single and ensemble supervised learning algorithms (e.g., random forest, support vector machine, decision tree, and scalable boosting techniques). Comparative analysis of the deployed models was performed to determine the best predictive model. Further, novel evaluation metrics for the confusion matrix of each model were introduced. The results showed that extreme gradient boosting and categorical boosting outperformed all the applied algorithms. They can predict well integrity failures with an accuracy of 100% using traditional or proposed metrics. Physical equations were also developed on the basis of feature importance extracted from the random forest algorithm. The developed model will help optimize company resources and dedicate personnel efforts to high-risk wells. As a result, progressive improvements in health, safety, and environment and business performance can be achieved.Cited as: Salem, A. M., Yakoot, M. S., Mahmoud, O. A novel machine learning model for autonomous analysis and diagnosis of well integrity failures in artificial-lift production systems. Advances in Geo-Energy Research, 2022, 6(2): 123-142. https://doi.org/10.46690/ager.2022.02.0

Study of efficacy and safety of a new local cream ("healer") in the treatment of chronic anal fissure: a prospective, randomized, single-blind, comparative study Estudo da eficácia e segurança de novo creme cicatrizante para o tratamento da fissura anal crônica: estudo prospectivo, randomizado, simples-cego e comparativo

OBJECTIVES: To determine the efficacy and safety of "healer" cream as monotherapy in the treatment of acute and chronic anal fissure. STUDY DESIGN: A prospective, randomized, single blinded, comparative trial. METHODS: Sixty patients suffering from anal fissure were included in the study. Patients were randomly divided into three groups: group A: treated with "healer" local cream application 3 times daily; group B: treated with nitroglycerine 0.25% local cream 3 times daily; group C: treated with a lidocaine 2% cream applied locally 3 times daily. All the followings were followed up and compared between groups. (1) Visual pain analogue score after defecation; (2) severity of straining and discomfort during defecation; (3) frequency of ulcer healed at 30 days; (4) any side effects or complications. RESULTS: The pain scoring after defecation was significantly reduced in the three treatment groups. The group treated with "healer" isosorbide-di-nitrate showed the greatest reduction of the visual pain analogue score median from 9 before treatment to 3 & 1 after 10 and 20 days respectively, while the median visual pain analogue score in group B treated with nitroglycerine cream was 9 reduced to 4 & 2 after 10 and 20 days respectively, and the median visual pain analogue score in lidocaine group only dropped from 9 to 6 and 4, respectively. The reduction of both pain scoring and defecation scoring with "healer" was statistically significantly greater than the other two treatments by Kruskal-Wallis test, POBJETIVOS: Determinar a eficácia e segurança de "creme cicatrizante" (dinitrato de isosorbida 1%; lidocaína 2%; rutosídios 5% em base de creme anti-séptico) como monoterapia no tratamento da fissura anal aguda ou crônica. METODOLOGIA: Estudo prospectivo, randomizado, simples-cego, comparativo. Foram incluídos 60 pacientes com fissura anal. Foram divididos randomicamente em três grupos: grupo A: tratados com "creme cicatrizante", grupo B: tratados com creme de nitroglicerina 0,25% e grupo C: tratados com creme de lidocaína 2% aplicado. Em todos foi feita aplicação local 3 vezes ao dia. Os seguintes parâmetros foram aferidos: 1) escore analógico visual de dor após defecação, 2) severidade de esforço e desconforto para evacuar, 3) frequência da cicatrização após 30 dias, 4) presença de efeitos colaterais ou complicações. RESULTADOS: O escore de dor após a defecação foi reduzido significativamente nos três grupos. O grupo tratado com creme cicatrizante mostrou grande redução do escore médio de 9 para 3 e 1 após 10 e 20 dias de tratamento, respectivamente, enquanto que a média do grupo B foi reduzida de 9 para 4 e 2 e do grupo C de 9 para 6 e 4 após 10 e 20 dias de tratamento, respectivamente. A redução tanto da dor como do desconforto evacuatório com o uso de "creme cicatrizante" foi significativo em comparação com os outros cremes pelo teste de Kruskal-Wallis, P<0,001. O número de pacientes que referiram alívio completo e passagem fácil da fezes após 10 dias de tratamento foi maior e significativo no grupo A pelo teste Pearson, P<0,001. Após 30 dias, as fissuras estavam cicatrizadas em 18 (90%) pacientes do grupo A, em 12 (60%) do grupo B e em apenas 6 (30%) do grupo C. Qui ao quadrado = 15 (P = 0,001). CONCLUSÃO: O "creme cicatrizante" é um tratamento que promete ser promissor e seguro na fissura anal aguda ou crônica. A característica farmacocinética do creme leva a um melhor efeito que a nitroglicerina quanto a cicatrização (ação mais prolongada). Possivelmente cause menos cefaléia que a nitroglicerina devido a sua absorção ser mais lenta e causar uma curva de concentração mais suave do medicamento

Effect of Memo&reg;, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment

Mostafa Yakoot,1 Amel Salem,2 Sherine Helmy3 1Green Clinic and Research Center, 2Mabarrah Clinics, 3Pharco Pharmaceutical Industries, Alexandria, Egypt Background: Mild cognitive impairment encompasses the clinical continuum between physiologic age-related cognitive changes and dementia. A variety of medications, including herbal preparations (in particular Ginkgo biloba and Panax ginseng), have been advocated as treatments for cognitive impairment in the elderly. In this study, we investigated the effect of an already marketed dietary supplement (Memo&reg;) combining 750 mg of lyophilized royal jelly with standardized extracts of G. biloba 120 mg and P. ginseng 150 mg on Mini-Mental State Examination (MMSE) scores in patients with mild cognitive impairment. Methods: Sixty-six subjects presenting with forgetfulness and satisfying the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) clinical criteria for mild cognitive impairment were randomly divided into an experimental group treated with one Memo capsule before breakfast daily for 4 weeks and a control group who took placebo. The mean change in MMSE score from baseline and reported adverse effects were compared between the two groups. Results: The mean change in MMSE score in the group treated with Memo for 4 weeks was significantly greater than in the control group (+2.07 versus +0.13, respectively) by the Student&rsquo;s t-test (t = 6.485, P &lt; 0.0001). This was also true after adjusting for age as a covariate and educational level as a factor nested within the treatment groups in a general linear model (analysis of covariance, F = 9.675 [corrected model], P &lt; 0.0001). Conclusion: This combined triple formula may be beneficial in treating the cognitive decline that occurs during the aging process as well as in the early phases of pathologic cognitive impairment typical of insidious-onset vascular dementia and in the early stages of Alzheimer&rsquo;s disease. Larger-sized studies with longer treatment durations are needed to confirm this. Keywords: mild cognitive impairment, Alzheimer&rsquo;s disease, vascular dementia, Mini-Mental State Examinatio

Pilot study of the efficacy and safety of lettuce seed oil in patients with sleep disorders

Mostafa Yakoot1, Sherine Helmy2, Kamal Fawal31Green Clinic Research Center, 2Pharco Pharmaceutical Company, 3Mamorah Psychiatric Hospital, Alexandria, EgyptBackground: Lactuca sativa (garden lettuce) is a popular salad herb. It has been in use in folk medicine since ancient times as both an appetite stimulant and as an aid to sleep. L. sativa seed oil (Sedan&amp;reg;) has demonstrated a pronounced sedative effect and potentiated the hypnotic effect of barbiturates in animal models. It also exhibited significant analgesic and anti-inflammatory activities. In this study, we evaluated the sedative and hypnotic effects of L. sativa in patients suffering from insomnia.Methods: Sixty patients suffering from insomnia with or without anxiety were randomized to receive capsules containing L. sativa seed oil 1000 mg (n = 30) or placebo (n = 30). All patients were asked to complete a verbal questionnaire before the start of the trial and 1 week after starting treatment.Results: Improvements in the modified State-Trait Anxiety Inventory and the Sleep rating scale scores were significantly greater in patients receiving L. sativa seed oil compared with those on placebo (P &amp;lt; 0.05). No side effects were found to be attributable to L. sativa seed oil at the given dosage.Conclusion: L. sativa seed oil was found to be a useful sleeping aid and may be a hazard-free line of treatment, especially in geriatric patients suffering from mild-to-moderate forms of anxiety and sleeping difficulties.Keywords: Lactuca sativa seed oil, insomnia, sleeping disorder, anxiet